Characterizing Effects of Erenumab on Patients with Menstrually-Related Migraines

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Migraine
  • Age: Between 18 - 55 Years
  • Gender: Female
  • Other Inclusion Criteria:
    1. Female patients between age 18 – 55 treated at NYU Langone Health
    2. Diagnosis of migraine headaches
    3. Current or prior use of erenumab for migraine treatment, for at least 3 consecutive months

You may not be eligible for this study if the following are true:

    1. Does not meet the inclusion criteria



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.